Comment from Children's Tumor Foundation

Summary: The Children’s Tumor Foundation (CTF) supports the FDA's Rare Disease Innovation Hub and requests that the agency include a workshop on "Unlocking Shelved Assets for Rare Disease" in its fall 2026 programming. The foundation argues for creating incentives and regulatory pathways to identify, transfer, and develop drug assets that have been de-prioritized or abandoned by pharmaceutical companies.